Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Stauffer Larsen

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Ugeskrift for Laeger|April 10, 2008
[Tyrosine kinase inhibitors in the treatment of polycythemia vera and related conditions. Danish Society of Hematology]Thomas Stauffer Larsen, Hans Carl Hasselbalch,
Critical Reviews in Oncology/Hematology|January 22, 2019
Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic reviewJelena Jelicic, Thomas Stauffer Larsen, Milos Maksimovic, et al.
Critical Reviews in Oncology/Hematology|July 11, 2021
The clinical applicability of current prognostic models in follicular lymphoma: A systematic reviewJelena Jelicic, Thomas Stauffer Larsen, Zoran Bukumiric, et al.
Journal of Clinical Apheresis|March 24, 2018
Impact of apheresis automation on procedure quality and predictability of CD34<sup>+</sup> cell yieldNelly Besson, Mie Topholm Bruun, Thomas Stauffer Larsen, et al.
British Journal of Haematology|February 23, 2007
The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disordersThomas Stauffer Larsen, Jacob Haaber Christensen, Hans Carl Hasselbalch, et al.
Cancer Genetics and Cytogenetics|January 11, 2007
A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosisThomas Stauffer Larsen, Hans Carl Hasselbalch, Niels Pallisgaard, et al.
BMJ Case Reports|September 5, 2015
Primary thymic extranodal marginal zone B cell lymphoma as an incidental finding in a Caucasian womanJeanette Krogh Petersen, Thomas Stauffer Larsen, Michael Boe Møller, et al.
Hematology (Amsterdam, Netherlands)|July 12, 2008
High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burdenThomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, et al.
European Journal of Haematology|October 27, 2007
The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotypeThomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, et al.
BMJ Case Reports|September 3, 2014
Primary CNS lymphoma in a patient treated with azathioprineMatilde Kanstrup Glesner, Lukas Frans Ocias, Thomas Stauffer Larsen, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Ugeskrift for Laeger|April 10, 2008
[Tyrosine kinase inhibitors in the treatment of polycythemia vera and related conditions. Danish Society of Hematology]Thomas Stauffer Larsen, Hans Carl Hasselbalch,
Critical Reviews in Oncology/Hematology|January 22, 2019
Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic reviewJelena Jelicic, Thomas Stauffer Larsen, Milos Maksimovic, et al.
Critical Reviews in Oncology/Hematology|July 11, 2021
The clinical applicability of current prognostic models in follicular lymphoma: A systematic reviewJelena Jelicic, Thomas Stauffer Larsen, Zoran Bukumiric, et al.
Journal of Clinical Apheresis|March 24, 2018
Impact of apheresis automation on procedure quality and predictability of CD34<sup>+</sup> cell yieldNelly Besson, Mie Topholm Bruun, Thomas Stauffer Larsen, et al.
British Journal of Haematology|February 23, 2007
The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disordersThomas Stauffer Larsen, Jacob Haaber Christensen, Hans Carl Hasselbalch, et al.
Cancer Genetics and Cytogenetics|January 11, 2007
A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosisThomas Stauffer Larsen, Hans Carl Hasselbalch, Niels Pallisgaard, et al.
BMJ Case Reports|September 5, 2015
Primary thymic extranodal marginal zone B cell lymphoma as an incidental finding in a Caucasian womanJeanette Krogh Petersen, Thomas Stauffer Larsen, Michael Boe Møller, et al.
Hematology (Amsterdam, Netherlands)|July 12, 2008
High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burdenThomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, et al.
European Journal of Haematology|October 27, 2007
The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotypeThomas Stauffer Larsen, Niels Pallisgaard, Michael Boe Møller, et al.
BMJ Case Reports|September 3, 2014
Primary CNS lymphoma in a patient treated with azathioprineMatilde Kanstrup Glesner, Lukas Frans Ocias, Thomas Stauffer Larsen, et al.
Pageof 10